CoChat

Antiangiogenic Effect of Angiotensin II Type 2 Receptor in Ischemia-Induced Angiogenesis in Mice Hindlimb

Silvestre, Jean-Sébastien, Tamarat, Radia, Senbonmatsu, Takaaki, Icchiki, Toshihiro, Ebrahimian, Teni, Iglarz, Marc, Besnard, Sandrine, Duriez, Micheline, Inagami, Tadashi, Lévy, Bernard I. · 2002 · Circulation Research
Cited by 105

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

This study examined the potential role of angiotensin type 2 (AT 2 ) receptor on angiogenesis in a model of surgically induced hindlimb ischemia. Ischemia was produced by femoral artery ligature in both wild-type and AT 2 gene–deleted mice ( Agtr2 − /Y). After 28 days, angiogenesis was quantitated by microangiography, capillary density measurement, and laser Doppler perfusion imaging. Protein levels of vascular endothelial growth factor (VEGF), endothelial nitric oxide synthase (eNOS), Bax, and Bcl-2 were determined by Western blot analysis in hindlimbs. The AT 2 mRNA level (assessed by semiquantitative RT-PCR) was increased in the ischemic hindlimb of wild-type mice. Angiographic vessel density and laser Doppler perfusion data showed significant improvement in ischemic/nonischemic leg ratio, 1.9- and 1.7-fold, respectively, in Agtr2 − /Y mice compared with controls. In ischemic leg of Agtr2 − /Y mice, revascularization was associated with an increase in the antiapoptotic protein content, Bcl-2 (211% of basal), and a decrease (60% of basal) in the number of cell death, determined by TUNEL method. Angiotensin II treatment (0.3 mg/kg per day) raised angiogenic score, blood perfusion, and both VEGF and eNOS protein content in ischemic leg of wild-type control but did not modulate the enhanced angiogenic response observed in untreated Agtr2 − /Y mice. Finally, immunohistochemistry analysis revealed that VEGF was mainly localized to myocyte, whereas eNOS-positive staining was mainly observed in the capillary of ischemic leg of both wild-type and AT 2 -deficient mice. This study demonstrates for the first time that the AT 2 receptor subtype may negatively modulate ischemia-induced angiogenesis through an activation of the apoptotic process.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.res.0000019892.41157.24

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 105

Metadata

Authors
Silvestre, J.-S., Tamarat, R., Senbonmatsu, T., Icchiki, T., Ebrahimian, T., Iglarz, M., Besnard, S., Duriez, M., Inagami, T., & Lévy, B. I.
Venue
Circulation Research
Published
2002-05-31
Volume
90
Issue
10
Pages
1072-1079
ISSN
  • 0009-7330 (ISSN-L)
  • 1524-4571
OpenAlex
W2107274709
Cited by
105
References
1
FWCI
3.13
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antiangiogenic Effect of Angiotensin II Type 2 Receptor in Ischemia-Induced Angiogenesis in Mice Hindlimb. https://app.cochat.ai/papers/10.1161/01.res.0000019892.41157.24
The paper
Silvestre, J.-S., Tamarat, R., Senbonmatsu, T., Icchiki, T., Ebrahimian, T., Iglarz, M., Besnard, S., Duriez, M., Inagami, T., & Lévy, B. I. (2002). Antiangiogenic Effect of Angiotensin II Type 2 Receptor in Ischemia-Induced Angiogenesis in Mice Hindlimb. Circulation Research. https://doi.org/10.1161/01.res.0000019892.41157.24

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.